Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€102.18

€102.18

-3.150%
-3.32
-3.150%
€169.78
 
17.05.24 / Tradegate WKN: 927079 / Symbol: ILMN / Name: Illumina / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Illumina Inc. Stock

Illumina Inc. took a tumble today and lost -€3.320 (-3.150%).
Our community is currently high on Illumina Inc. with 19 Buy predictions and 4 Sell predictions.
As a result the target price of 169 € shows a very positive potential of 65.39% compared to the current price of 102.18 € for Illumina Inc..
For the coming years our community has positive and negative things to say abot the Illumina Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.

Pros and Cons of Illumina Inc. in the next few years

Pros
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Illumina Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Illumina Inc. -3.150% -0.409% -7.830% -43.913% -20.482% -67.250% -63.403%
QuidelOrtho Corp. 0.490% -2.475% 8.242% -50.365% -41.905% -58.778% -
Boston Scientific -0.720% 0.730% 7.813% 40.073% 34.137% 101.108% 107.114%
Waters Corp. -0.030% 0.491% 8.879% 30.960% 8.411% 27.891% 75.814%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-11-11

Given a brief glance, Illumina with the US symbol (ILMN) seemingly presents an interesting financial scenario. There exist varied factors in the financials that catch attention, while certain aspects bespeak areas the company needs to address. However, it is important to delve deeper into the data for a comprehensive understanding.

The gross profit as per the Trailing Twelve Months (TTM) indicates a prospect reassuringly. The GrossProfitTTM is 3145000000, referring to overall revenue's percentage that the company retains after direct costs associated with making the products have been considered. Maintaining a healthy gross margin suggests productive internal cost management and pricing policies compared to competitors.

In terms of the company's market appeal indicated by the Price-to-Sales (PriceSalesTTM: 6.6241) and Price-to-Book (PriceBookMRQ: 4.8854) ratios. Both are less than the commonly used threshold of 10 for overvalued prospects, indicating a potentially undervalued situation assuming sustained performance. Thus, for investors keen on value investing, Illumina could be an interesting opportunity.

Comments

Illumina, Inc. (NASDAQ: ILMN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for ILMN provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -5.16%
Target price 157.692
Change
Ends at 07.05.25

Illumina, Inc. (NASDAQ: ILMN) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $170.00 price target on the stock.
Ratings data for ILMN provided by MarketBeat
Show more

Prediction Sell
Perf. (%) -16.33%
Target price 93.050
Change
Ends at 10.04.25

Illumina, Inc. (NASDAQ: ILMN) had its price target raised by analysts at Barclays PLC from $85.00 to $100.00. They now have an "underweight" rating on the stock.
Ratings data for ILMN provided by MarketBeat
Show more

News

Why Illumina Stock Zoomed Higher on Thursday: https://g.foolcdn.com/editorial/images/770227/medical-professional-working-at-a-computer-terminal.jpg
Why Illumina Stock Zoomed Higher on Thursday

A legal opinion on the other side of Planet Earth put some juice into Illumina's (NASDAQ: ILMN) stock on Thursday. The gene-sequencing specialist saw its share price rise by over 3%, against the S&P

Why Illumina Stock Mashed the Market on Monday: https://g.foolcdn.com/editorial/images/766928/medical-professional-holding-dollar-sign-paperweight.jpg
Why Illumina Stock Mashed the Market on Monday

Gene-sequencing stock Illumina (NASDAQ: ILMN) was a standout in the biotech sector Monday, with its share-price rise convincingly beating the S&P 500 index. Investors were cheered by a stock buy

Why Illumina Rallied 36.6% in December: https://g.foolcdn.com/editorial/images/760588/scientist-altering-dna-genome-project.jpg
Why Illumina Rallied 36.6% in December

Shares of gene sequencing leader Illumina (NASDAQ: ILMN) rallied 36.6% in December, according to data from S&P Global Market Intelligence.

Investors might not be quite so excited, as Illumina